Qiagen   Report issue

For profit Phase 4
Founded: Venlo Netherlands (1984)
Status: Acquired by Thermo Fisher Scientific (2020)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

QIAGEN Gaithersburg, Inc

Active Ingredients

Drugs in Phase 4 Trials (1)

Key: Qiagen (0) Acquired (1)

isoniazid (nydrazid) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 1